Psychopathology in rare genetic neurodevelopmental disorders
Our aim is to improve the care and management of rare genetic NDs by constructing a concept of personalized healthcare. To achieve this, we aim to better understand the underlying neurocognitive and biological mechanisms to open doors for investigating new therapeutic interventions.
Next generation genetic studies in rare neurodevelopmental disorders (NDs) have spectacularly increased diagnostic yield.. The majority of Mendelian causes of NDs as intellectual disability (ID) and autism spectrum disorders (ASD) can now be identified. This enables detailed characterization and identification of syndromes based on their genetic etiology.
One of the major issues we experience in dealing with patients affected by ND syndromes is related to their psychopathology and behavioral problems, which have a great impact on quality of life of patients and their families.
In order to create tailored interventions, there is a strong need for research into the specific developmental and behavioral problems accompanying these syndromes.
We want to translate new knowledge of ND causation into better care for ND patients. Therefore I am dedicated to coordinate patient care and research activities at the approved Radboudumc Expert Centre for Rare Genetic Neurodevelopmental Disorders. Our research on rare ND disorders is shifting from syndrome discovery to development of etiology-based strategies for personalized management and therapy.
We recently defined several novel syndromes mainly based on the somatic and developmental phenotype (f.i SIN3A, POGZ, DDX3X, USP9X). The next challenge is to establish procedures for a more complete assessment of the clinical profile of these patients by systematically collecting measures on development, behaviour, and cognition. Understanding the natural course of NDs is mandatory to identify key milestones in disease progression, which is crucial to the design of clinical trials or other intervention tools.
We established vulnerability to psychotic disorders for the Kleefstra syndrome and published recent intervention recommendations. Neurocognitive and psychiatric studies related to other syndromes SIN3A-, KBG-, CTNNB1- and Kabuki syndromes is ongoing.
The Clinical Neurogenetics is closely affiliated with the following research groups:
- Molecular Neurogenetics (Prof. Dr. Hans van Bokhoven)
- Drosophila models of brain disorders (Dr. Annette Schenck)
- Genomic technologies and bioinformatics (Dr. C. Gillissen)
- Human Genetics (Prof. H. Brunner)
- Molecular Neurophysiology (Dr. Nael Nadif Kasri)
- Contextual neuropsychology (Prof. Jos Egger)
- Translational Genomics (Dr. L. Vissers)
- Translational research in Autism Spectrum Disorders (Prof. W. Staal)
Contact | |
Name: | Tjitske Kleefstra |
Telephone: | 0031 (0)24-36 13946 |
Email: | tjitske.kleefstra@radboudumc.nl |
Visiting address: | Radboud University Medical Centre Department of Human Genetics route 855 Geert Grooteplein 10 6525 GA Nijmegen The Netherlands |
Postal address: | Radboud University Medical Centre HP 855 Department of Human Genetics P.O. Box 9101 6500 HB Nijmegen The Netherlands |
Projects |
|
|
|
|
|
Key grants and prizes |
|
|
|
|
|
Key publications |
|
|
|
|
|
Links
Back to:
Theme 3:
Plasticity and Memory
Research Group
Psychopathology in rare genetic neurodevelopmental disorders
Principal Investigator
Prof. dr. T. Kleefstra
Group members
PhDs
Elke de Boer
Linde van Dongen (promotie dec '20)
Joost Kummeling
Lot Snijders Blok
Lara van Renssen
Dmitrijs Rots
Jet van der Spek
update OCT 20 EL